|
Code
|
51262
|
|
MA number
|
15/0303/08-S
|
|
Product Form:
|
sol ifc 10x2 ml/300 mg (amp.skl.)
|
|
MA Status:
|
D - Marketing Authorisation valid for an unlimited period
|
|
Type of procedure:
|
Mutual recognition procedure
|
|
Therapeutic Class:
|
15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM)
|
|
ATC:
|
| J |
ANTIINFECTIVES FOR SYSTEMIC USE |
| J01 |
ANTIBACTERIALS FOR SYSTEMIC USE |
| J01F |
MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
| J01FF |
Lincosamides |
| J01FF01 |
Clindamycin |
|
|
Shelf life:
|
18 |
|
Container:
|
glass ampoule
|
|
Route of admin.:
|
Intramuscular or intravenous use
|
PIL_Clindamycin Kabi 150mg sol ifc_12.2021.pdf
